These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4822124)

  • 1. [Permeability of the blood-aqueous barrier during inhibition of fibrinolysis in blood serum].
    Rudobielski R
    Klin Oczna; 1974 Mar; 44(3):239-42. PubMed ID: 4822124
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of blood fibrinolytic activity on blood-aqueous humor barrier permeability].
    Rudobielski R
    Klin Oczna; 1973 Dec; 43(12):1349-51. PubMed ID: 4769379
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood-aqueous barrier changes during activation of fibrinolysis in plasma].
    Rudobielski R
    Klin Oczna; 1974 Feb; 44(2):129-33. PubMed ID: 4453093
    [No Abstract]   [Full Text] [Related]  

  • 4. [Relationship between the state of blood-aqueous barrier and the fibrinolytic activity as well as plasma fibrinogen level].
    Rudobielski R
    Klin Oczna; 1974 Feb; 44(2):123-7. PubMed ID: 4453092
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrinogen after massive haemorrhage. Studies on coagulation and fibrinolysis of blood and lymph in dogs.
    Leandoer L
    Acta Chir Scand Suppl; 1968; 390():1-20. PubMed ID: 5275171
    [No Abstract]   [Full Text] [Related]  

  • 6. The in-vivo-effect of E-aminocaproic acid (EACA) on human plasma fibrinolytic system.
    Niewiarowski S; Wolosowicz N
    Thromb Diath Haemorrh; 1966 May; 15(3):491-500. PubMed ID: 4865186
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the effect of E-aminocaproic acid on the permeability of capillary vessels].
    Dzizinskiĭ AA; Kochergina TK; Seregina NM
    Farmakol Toksikol; 1968; 31(4):425-6. PubMed ID: 5698132
    [No Abstract]   [Full Text] [Related]  

  • 8. [In vitro fibrinolysis of the buffer coat coagulum].
    Harms D; Schmalisch N
    Frankf Z Pathol; 1966; 75(2):148-57. PubMed ID: 5995081
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological enhancement and short-term stimulation of blood fibrinolytic activity.
    Laursen B; Gormsen J
    Scand J Haematol; 1969; 6(6):402-8. PubMed ID: 5374117
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro inhibition of streptokinase-induced proteolysis by Trasylol and by epsilon amino caproic acid (EACA).
    Godal HC; Theodor I
    Scand J Clin Lab Invest; 1965; 17():Suppl 84:199+. PubMed ID: 5295419
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental investigations with proteinase inhibitors.
    Nordström S; Blombäck M; Olsson P; Zetterqvist E
    Acta Chir Scand Suppl; 1967; 378():33-40. PubMed ID: 5300105
    [No Abstract]   [Full Text] [Related]  

  • 12. [Permeability of the blood aqueous barrier following retinal detachment surgery].
    Pecoldowa K; Bartkowska-Orlowska M
    Klin Oczna; 1972; 42(5):1235-9. PubMed ID: 4637335
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of fibrinolytic inhibitors and heparin on induced intravascular coagulation.
    Nordström S
    Acta Physiol Scand Suppl; 1970; 337():1-35. PubMed ID: 5311663
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of phenphormin on blood fibrinolysis in diabetes mellitus.
    Fiaschi E; Barbui T; Previato G; Di Luzio V; Guarnieri GF; Todesco S
    Arzneimittelforschung; 1969 Apr; 19(4):638-40. PubMed ID: 5819165
    [No Abstract]   [Full Text] [Related]  

  • 15. The coagulation disorder in promyelocytic leukemia.
    Straub PW; Frick PG
    Helv Med Acta; 1967 Dec; 34(1):44-53. PubMed ID: 5242897
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrinogen content and fibrinolytic activity of blood in diabetics, before and after antidiabetic drugs.
    Bedi HK; Vyas BR; Bomb BS; Agarwal ML; Bedi T
    J Assoc Physicians India; 1977 Mar; 25(3):181-5. PubMed ID: 914747
    [No Abstract]   [Full Text] [Related]  

  • 17. [Change in plasma esterase activity during stimulation of the "2d anticoagulation system"].
    Baskova IP; Cherkesova DU; Orlova AS; Kudriashov BA
    Vopr Med Khim; 1974; 20(5):482-9. PubMed ID: 4456798
    [No Abstract]   [Full Text] [Related]  

  • 18. Clot lysis in a perfusion system.
    Bouvier CA; Gruendlinger J; Berthoud S
    Thromb Diath Haemorrh; 1966 Jan; 15(1):205-19. PubMed ID: 5919801
    [No Abstract]   [Full Text] [Related]  

  • 19. Study of the defibrination syndrome associated with acute hepatic failure.
    Tan BH; Mori K; Richter D; Quinlan R; Gans H
    Surg Gynecol Obstet; 1971 Feb; 132(2):263-74. PubMed ID: 4993879
    [No Abstract]   [Full Text] [Related]  

  • 20. Recovery of fibrinogen in fibrinolytic dogs. Influence of split products.
    Young MC; Kolmen SN
    Thromb Diath Haemorrh; 1970 Feb; 23(1):50-7. PubMed ID: 5420434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.